Abbott wins CE Mark for Amulet 360 heart device in Europe

August 27, 2026 9:00 AM

Abbott (NYSE: ABT) has received CE Mark approval for its Amulet 360 Left Atrial Appendage (LAA) Occluder, a device designed ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found